SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon board to consider recommendation of final dividend

17 Apr 2018 Evaluate

With reference to the earlier intimation dated April 05, 2018 of next Board meeting, Biocon has now informed about consideration and recommendation of final dividend, if any, for the financial year 2017-18 forms part of the agenda of the meeting of Board of Directors of the company, scheduled on April 26, 2018.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

383.80 3.05 (0.80%)
07-May-2026 13:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.40
Dr. Reddys Lab 1306.00
Cipla 1371.30
Zydus Lifesciences 938.90
Lupin 2456.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×